Actively Recruiting
Effects of Calamansi on Blood Glucose and Insulin Levels
Led by Burapha University · Updated on 2026-05-14
54
Participants Needed
1
Research Sites
39 weeks
Total Duration
On this page
Sponsors
B
Burapha University
Lead Sponsor
F
Faculty of Allied Health Sciences
Collaborating Sponsor
AI-Summary
What this Trial Is About
Fifty-four healthy sedentary male and female participants aged 18-30 years will be recruited for this study. Participants will be randomly assigned to one of two groups: a control group receiving placebo MMC capsules (n = 27) or a calamansi capsule supplementation group (n = 27). All participants will undergo health screening procedures, including medical history assessment, mental health questionnaire evaluation, and measurements of vital signs, height, body weight, and body composition. Venous blood samples will subsequently be collected to determine blood glucose, insulin, creatinine, alanine aminotransferase (ALT), and malondialdehyde (MDA) levels. These assessments will be performed at three time points: 1) before capsule supplementation (baseline), 2) following a single dose of capsule supplementation, and 3) after 12 weeks of supplementation.
CONDITIONS
Official Title
Effects of Calamansi on Blood Glucose and Insulin Levels
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Healthy individuals without diabetes or prediabetes and fasting blood glucose less than 100 mg/dL after 8 hours of fasting
- Aged between 18 and 30 years, male or female
- Body Mass Index (BMI) between 18.5 and 22.9 kg/m²
- No diseases affecting blood sugar levels such as liver or pancreatic diseases
You will not qualify if you...
- Pregnant or breastfeeding women
- Regular smokers
- Regular alcohol consumers
- History of allergies to citrus fruits or citrus-derived ingredients
- Taking medications that affect glucose metabolism and fat distribution, including steroids, protease inhibitors, and psychiatric medications such as antidepressants, antipsychotics, and mood stabilizers
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Piyapong Prasertsri
Mueang, Burapha University, Thailand, 20131
Actively Recruiting
Research Team
P
Piyapong Prasertsri, Ph.D.
CONTACT
K
Kulwara Poolpol, Ph.D.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here